{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:24:11Z","timestamp":1777922651345,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p>\n                    Urogenital\n                    <jats:italic toggle=\"yes\">Neisseria gonorrhoeae<\/jats:italic>\n                    isolates (266) collected in San Francisco, CA, in 2009 were analyzed for antimicrobial susceptibility and were subsequently genotyped by\n                    <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic>\n                    multiantigen sequence typing (NG-MAST). Isolates of identical or closely related sequence types were found to possess highly similar phenotypes with regard to drug susceptibility. Isolates containing decreased susceptibility to oral cephalosporins were detected in 2009 and were found to contain the mosaic\n                    <jats:italic toggle=\"yes\">penA<\/jats:italic>\n                    allele (XXXIV) found previously to be associated with decreased susceptibility to cephalosporins. A better understanding of the relationships between phenotypic and genotypic markers for antimicrobial resistance may be helpful to the development of effective surveillance systems for drug-resistant\n                    <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1089\/mdr.2011.0229","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T15:43:54Z","timestamp":1339429434000},"page":"510-517","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Using the\n                    <i>Neisseria gonorrhoeae<\/i>\n                    Multiantigen Sequence-Typing Method to Assess Strain Diversity and Antibiotic Resistance in San Francisco, California"],"prefix":"10.1177","volume":"18","author":[{"given":"Sean","family":"Buono","sequence":"first","affiliation":[{"name":"San Francisco Department of Public Health Laboratory, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Wu","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health Laboratory, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Hess","sequence":"additional","affiliation":[{"name":"Santa Clara University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Carlson","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health Laboratory, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Rauch","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health Laboratory, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Philip","sequence":"additional","affiliation":[{"name":"Division of STD Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pennan","family":"Barry","sequence":"additional","affiliation":[{"name":"Division of STD Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Division of STD Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Klausner","sequence":"additional","affiliation":[{"name":"Division of STD Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Pandori","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health Laboratory, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00788-10","article-title":"Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada","volume":"55","author":"Allen V.G.","year":"2011","unstructured":"Allen V.G., , Farrell D.J., , Rebbapragada A., , Tan J., , Tijet N., , Perusini S.J., , Towns L., , Lo S., , Low D.E., , Melano R.G. 2011. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob. Agents Chemother., 55:703\u2013712.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656560902731993"},{"key":"e_1_3_3_4_2","volume-title":"Sexually Transmitted Disease Surveillance 2009","author":"(CDC) Centers for Disease Control, Prevention","year":"2010","unstructured":"(CDC) Centers for Disease Control, Prevention. 2010. Sexually Transmitted Disease Surveillance 2009. U.S. Department of Health and Human Services: Atlanta, GA."},{"key":"e_1_3_3_5_2","first-page":"332","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2006: flouorquinolones no longer recommended for treatment of Gonococcal infections","volume":"56","author":"(CDC) Centers for Disease Control, Prevention","year":"2007","unstructured":"(CDC) Centers for Disease Control, Prevention. 2007. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: flouorquinolones no longer recommended for treatment of Gonococcal infections. MMWR, 56:332\u2013336.","journal-title":"MMWR"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated Gonococcal urethritis by double-dosing of 200\u2009mg cefixime at a 6-h interval","volume":"9","author":"Deguchi T.","year":"2003","unstructured":"Deguchi T. et al. 2003. Treatment of uncomplicated Gonococcal urethritis by double-dosing of 200\u2009mg cefixime at a 6-h interval. J. Infect. Chemother., 9:35\u201339.","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1128\/jb.173.17.5476-5486.1991","article-title":"Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes","volume":"173","author":"Dempsey J.A.","year":"1991","unstructured":"Dempsey J.A., , Litaker W., , Madhure A., , Snodgrass T.L., , Cannon J.G. 1991. Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes. J Bacteriol., 1991; 173:5476\u20135486.","journal-title":"J Bacteriol."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01734359"},{"key":"e_1_3_3_9_2","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall T.A.","year":"1999","unstructured":"Hall T.A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucl. Acids. Symp. Ser., 41:95\u201398.","journal-title":"Nucl. Acids. Symp. Ser."},{"key":"e_1_3_3_10_2","unstructured":"\u201cGonococcal Isolate Surveillance Project (GISP) Protocol\u201dUpdated: July 2010www.cdc.gov\/std\/gisp\/(Online.)"},{"issue":"14","key":"e_1_3_3_11_2","article-title":"Gonorrhea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison C.A.","year":"2011","unstructured":"Ison C.A., , Hussey J., , Sankar K.N., , Evans J., , Alexander S. 2011. Gonorrhea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill., 16,14pii: 19833.","journal-title":"Euro Surveill."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-011-0169-9"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/383047"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01800-07"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?.: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi M.","year":"2011","unstructured":"Ohnishi M., , Golparian D., , Shimuta K., , Saika T., , Hoshina S., , Iwasaku K., , Nakayama S., , Kitawaki J., , Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?.: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother., 55:3538\u20133545.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/sti.2008.029694","article-title":"Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing","volume":"84","author":"Palmer H.M.","year":"2008","unstructured":"Palmer H.M., , Young H., , Graham C., , Dave J. 2008. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect., 84:280\u2013284.","journal-title":"Sex. Transm. Infect."},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","article-title":"Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California","volume":"53","author":"Pandori M.","year":"2009","unstructured":"Pandori M., , Barry P.M., , Wu A., , Ren A., , Whittington W.L.H., , Liska S., , Klausner J.D. 2009. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob. Agents Chemother., 53:4032\u20134034.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/AAC.00626-06","article-title":"Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae","volume":"50","author":"Takahata S.","year":"2006","unstructured":"Takahata S., , Senju N., , Osaki Y., , Yoshida T., , Ida T. 2006. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother., 50:3638\u20133645.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"issue":"47","key":"e_1_3_3_20_2","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoeae treatment, Norway, 2010","volume":"15","author":"Unemo M.","year":"2010","unstructured":"Unemo M., , Golparian D., , Syversen G., , Vestrheim D.F., , Moi H. 2010. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoeae treatment, Norway, 2010. Euro. Surveil., 15,47pii:19721.","journal-title":"Euro. Surveil."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2010.0199"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment of gonorrhoeae","volume":"13","author":"Yokioi S.","year":"2007","unstructured":"Yokioi S. et al. 2007. Threat to cefixime treatment of gonorrhoeae. Emerg. Infect. Dis., 13:1275\u20131277.","journal-title":"Emerg. Infect. Dis."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2011.0229","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2011.0229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2011.0229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:26:52Z","timestamp":1777667212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2011.0229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1089\/mdr.2011.0229"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2011.0229","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}